Skip to content
Sharism- Lifestyle
Author:
Knoa Pharma
Knoa Pharma to Present Pipeline Assets at LSX Congress USA 2026
September 22, 2026
Knoa Pharma Board Appoints Michael Goettler as President and Chief Executive Officer
July 1, 2026
Knoa Pharma and GCAR Announce First Newly Diagnosed Glioblastoma Patient Randomized in Phase 2/3 GBM AGILE Evaluation of Tinostamustine and First Recurrent Patient Dosed
June 24, 2026
Knoa Pharma to Present Pipeline Assets at BIO International Convention 2026
June 22, 2026